Burney CO Organon & Co. Transaction History

Burney CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $14,057 - $17,271	-444 Reduced 5.96%	7,007 $236,000
Q1 2022 May 09, 2022	SELL	$30.45 - $39.36 $3,501 - $4,526	-115 Reduced 1.52%	7,451 $260,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $802 - $1,039	-28 Reduced 0.37%	7,566 $230,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $133,931 - $166,723	-4,678 Reduced 38.12%	7,594 $249,000
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $349,138 - $466,336	12,272 New	12,272 $371,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

Stay updated on Burney CO with notifications on news.